DNTH
Price
$18.33
Change
-$0.42 (-2.24%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
614.58M
LRMR
Price
$1.94
Change
+$0.01 (+0.52%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
131.9M
77 days until earnings call
Interact to see
Advertisement

DNTH vs LRMR

Header iconDNTH vs LRMR Comparison
Open Charts DNTH vs LRMRBanner chart's image
Dianthus Therapeutics
Price$18.33
Change-$0.42 (-2.24%)
Volume$3.85K
Capitalization614.58M
Larimar Therapeutics
Price$1.94
Change+$0.01 (+0.52%)
Volume$12.08K
Capitalization131.9M
DNTH vs LRMR Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. LRMR commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a StrongBuy and LRMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (DNTH: $18.75 vs. LRMR: $1.93)
Brand notoriety: DNTH and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 51% vs. LRMR: 90%
Market capitalization -- DNTH: $614.58M vs. LRMR: $131.9M
DNTH [@Biotechnology] is valued at $614.58M. LRMR’s [@Biotechnology] market capitalization is $131.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 3 TA indicator(s) are bullish while LRMR’s TA Score has 3 bullish TA indicator(s).

  • DNTH’s TA Score: 3 bullish, 6 bearish.
  • LRMR’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than LRMR.

Price Growth

DNTH (@Biotechnology) experienced а -0.79% price change this week, while LRMR (@Biotechnology) price change was +7.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

DNTH is expected to report earnings on Mar 11, 2025.

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($615M) has a higher market cap than LRMR($132M). DNTH YTD gains are higher at: -13.991 vs. LRMR (-50.129). DNTH (-101.45M) and LRMR (-105.02M) have comparable annual earnings (EBITDA) . DNTH has more cash in the bank: 275M vs. LRMR (158M). DNTH has less debt than LRMR: DNTH (1.49M) vs LRMR (4.87M). DNTH has higher revenues than LRMR: DNTH (6.24M) vs LRMR (0).
DNTHLRMRDNTH / LRMR
Capitalization615M132M466%
EBITDA-101.45M-105.02M97%
Gain YTD-13.991-50.12928%
P/E Ratio3.24N/A-
Revenue6.24M0-
Total Cash275M158M174%
Total Debt1.49M4.87M31%
FUNDAMENTALS RATINGS
DNTH vs LRMR: Fundamental Ratings
DNTH
LRMR
OUTLOOK RATING
1..100
5822
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7965
P/E GROWTH RATING
1..100
64100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (18) in the null industry is somewhat better than the same rating for DNTH (52). This means that LRMR’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for LRMR (100). This means that DNTH’s stock grew somewhat faster than LRMR’s over the last 12 months.

DNTH's SMR Rating (100) in the null industry is in the same range as LRMR (100). This means that DNTH’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (65) in the null industry is in the same range as DNTH (79). This means that LRMR’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's P/E Growth Rating (64) in the null industry is somewhat better than the same rating for LRMR (100). This means that DNTH’s stock grew somewhat faster than LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHLRMR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NILIX15.15N/A
N/A
Neuberger Berman International Sel I
VCGAX32.70N/A
N/A
VALIC Company I Systematic Core Fund
HASGX13.39N/A
N/A
Harbor Small Cap Growth Instl
OGLNX92.24N/A
N/A
Invesco Global R
GCAVX20.17N/A
N/A
GMO US Small Cap Value VI

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-1.88%
IMNM - DNTH
48%
Loosely correlated
-7.48%
ERAS - DNTH
47%
Loosely correlated
-4.69%
LRMR - DNTH
46%
Loosely correlated
-6.31%
CRNX - DNTH
45%
Loosely correlated
-4.53%
COGT - DNTH
45%
Loosely correlated
-6.21%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-6.31%
ERAS - LRMR
50%
Loosely correlated
-4.69%
ACLX - LRMR
50%
Loosely correlated
+8.26%
IMNM - LRMR
48%
Loosely correlated
-7.48%
SVRA - LRMR
48%
Loosely correlated
-7.18%
IDYA - LRMR
48%
Loosely correlated
-2.45%
More